Table I.

Summary of translocation data

Cell type Primary cilium PDGF-AA EIPA Translocation 
    µm 
NIH3T3 No (interphase) − − 60 ± 8.7 (17) 
NIH3T3 No (interphase) − 30 ± 3.0 (25) 
NIH3T3 No (interphase) − 60 ± 5.4 (26) 
NIH3T3 No (interphase) 33 ± 2.7 (25) 
NIH3T3 Yes − − 21 ± 3.6 (23) 
NIH3T3 Yes − 11± 1.8 (23) 
NIH3T3 Yes − 45 ± 5.7 (25) 
NIH3T3 Yes 13 ± 1.5 (26) 
WT MEF Yes − − 45 ± 4.2 (53) 
WT MEF Yes − 27 ± 4.4 (22) 
WT MEF Yes − 111 ± 5.4 (23) 
WT MEF Yes 15 ± 1.8 (20) 
Tg737orpk MEF No or very short − − 75 ± 5.7 (21) 
Tg737orpk MEF No or very short − 63 ± 5.7 (19) 
Tg737orpk MEF No or very short − 87 ± 7.8 (34) 
Tg737orpk MEF No or very short 57 ± 5.7 (30) 
Cell type Primary cilium PDGF-AA EIPA Translocation 
    µm 
NIH3T3 No (interphase) − − 60 ± 8.7 (17) 
NIH3T3 No (interphase) − 30 ± 3.0 (25) 
NIH3T3 No (interphase) − 60 ± 5.4 (26) 
NIH3T3 No (interphase) 33 ± 2.7 (25) 
NIH3T3 Yes − − 21 ± 3.6 (23) 
NIH3T3 Yes − 11± 1.8 (23) 
NIH3T3 Yes − 45 ± 5.7 (25) 
NIH3T3 Yes 13 ± 1.5 (26) 
WT MEF Yes − − 45 ± 4.2 (53) 
WT MEF Yes − 27 ± 4.4 (22) 
WT MEF Yes − 111 ± 5.4 (23) 
WT MEF Yes 15 ± 1.8 (20) 
Tg737orpk MEF No or very short − − 75 ± 5.7 (21) 
Tg737orpk MEF No or very short − 63 ± 5.7 (19) 
Tg737orpk MEF No or very short − 87 ± 7.8 (34) 
Tg737orpk MEF No or very short 57 ± 5.7 (30) 

The table summarizes the translocation data obtained for NIH3T3 cells, WT MEFs, and Tg737orpk MEFs in 5-h wound-healing assays as a function of (a) the presence or absence of a primary cilium, (b) the presence or absence of 50 ng/ml PDGF-AA, and (c) the presence or absence of 10 µM of the NHE1 inhibitor EIPA. The absence or presence of primary cilia was assessed by visual inspection and has also been previously described (Schneider et al., 2005). Translocation data are shown as mean ± SEM , with the number of cells shown in parenthesis.

or Create an Account

Close Modal
Close Modal